S
Shengjie Yang
Researcher at Peking Union Medical College
Publications - 24
Citations - 516
Shengjie Yang is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 13 publications receiving 131 citations.
Papers
More filters
Journal ArticleDOI
Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target.
Shengjie Yang,Xinye Li,Xinye Li,Fan Yang,Ran Zhao,Ran Zhao,Xiandu Pan,Xiandu Pan,Jiaqi Liang,Li Tian,Xiaoya Li,Xiaoya Li,Longtao Liu,Yanwei Xing,Min Wu +14 more
TL;DR: The TMAO-involved mechanisms of atherosclerotic CVD from the perspective of inflammation, inflammation-related immunity, cholesterol metabolism, and atherothrombosis are discussed.
Journal ArticleDOI
Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-/- Mice.
Min Wu,Shengjie Yang,Songzi Wang,Yu Cao,Ran Zhao,Ran Zhao,Xinye Li,Xinye Li,Yanwei Xing,Longtao Liu +9 more
TL;DR: It is demonstrated that both high and low-dose BBR can improve serum lipid and systemic inflammation levels, and alleviate atherosclerosis induced by high-fat diet in ApoE–/– mice.
Journal ArticleDOI
Roles and Mechanisms of Hawthorn and Its Extracts on Atherosclerosis: A Review.
TL;DR: It is revealed that the hawthorn extracts possess serum lipid-lowering, anti-oxidative, and cardiovascular protective properties, thus gaining popularity, especially for its anti-atherosclerotic effects.
Journal ArticleDOI
Role of Endoplasmic Reticulum Stress in Atherosclerosis and Its Potential as a Therapeutic Target.
Shengjie Yang,Min Wu,Xiaoya Li,Xiaoya Li,Ran Zhao,Ran Zhao,Yixi Zhao,Yixi Zhao,Longtao Liu,Songzi Wang +9 more
TL;DR: The role of ER stress in different types of cells in atherosclerotic lesions includes the activation of apoptotic and inflammatory pathways induced by prolonged ER stress, especially in advanced lesional macrophages and endothelial cells (ECs), as well as common atherosclerosis-related ER stressors in different lesional cells.
Journal ArticleDOI
Polydatin for treating atherosclerotic diseases: A functional and mechanistic overview.
TL;DR: The pharmacological mechanism of polydatin in anti-atherosclerosis, the biological characteristics of Polygonum cuspidatum, the toxicology and pharmacokinetics ofpolydatin and will provide ideas for further research are reviewed.